Paricalcitol Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients on Sevelamer Hydrochloride: Which Dialysate Calcium Concentration to Use?

Publisher： Karger

E-ISSN： 1421-9735|27|2|182-186

ISSN： 0253-5068

Source： Blood Purification, Vol.27, Iss.2, 2009-01, pp. : 182-186

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Study of Low Calcium Dialysate on Elderly Hemodialysis Patients with Secondary Hypoparathyroidism

By  

Blood Purification, Vol. 42, Iss. 1, 2016-02 ,pp. : 3-8

Karger

Access to resources Recommend Favorite

Effects of Treatment of Secondary Hyperparathyroidism on the Lipid Profile in Patients on Hemodialysis

By  

Blood Purification, Vol. 16, Iss. 1, 1998-02 ,pp. : 22-29

Karger

Access to resources Recommend Favorite

Treatment with Sevelamer Decreases Bicarbonate Levels in Hemodialysis Patients

By  

Nephron, Vol. 92, Iss. 2, 2002-09 ,pp. : 499-500

Karger

Access to resources Recommend Favorite

Effects of Lowering Dialysate Calcium Concentration on Carotid Intima-Media Thickness and Aortic Stiffness in Patients Undergoing Maintenance Hemodialysis: A Prospective Study

By  

Blood Purification, Vol. 42, Iss. 4, 2016-11 ,pp. : 337-346

Karger

Access to resources Recommend Favorite

Use of 2MD, a Novel Oral Calcitriol Analog, in Hemodialysis Patients with Secondary Hyperparathyroidism

By  

American Journal of Nephrology, Vol. 43, Iss. 3, 2016-04 ,pp. : 213-220

Karger

Access to resources Recommend Favorite